Effects of the replacement of the angiotensin converting enzyme inhibitor enalapril by the angiotensin II receptor blocker telmisartan in patients with congestive heart failure: The replacement of angiotensin converting enzyme inhibition (REPLACE) investigators

This publication has 17 references indexed in Scilit:

• Comparison of Changes in Respiratory Function and Exercise Oxygen Uptake With Losartan Versus Enalapril in Congestive Heart Failure Secondary to Ischemic or Idiopathic Dilated Cardiomyopathy
  The American Journal of Cardiology, 1997
• Angiotensin Receptors and Their Antagonists
  New England Journal of Medicine, 1996
• Overview of Randomized Trials of Angiotensin-Converting Enzyme Inhibitors on Mortality and Morbidity in Patients With Heart Failure
  JAMA, 1995
• Safety and tolerability of losartan potassium, an angiotensin II receptor antagonist, compared with hydrochlorothiazide, atenolol, felodipne ER, and angiotensin-converting enzyme inhibitors for the treatment of systemic hypertension
  The American Journal of Cardiology, 1995
• Losartan in Heart Failure
  Circulation, 1995
• Heart failure in the 1990s: Evolutions of a major public health problem in cardiovascular medicine
  Journal of the American College of Cardiology, 1993
• Epidemiology of heart failure in the United States
  American Heart Journal, 1993
• Effect of Enalapril on Survival in Patients with Reduced Left Ventricular Ejection Fractions and Congestive Heart Failure
  New England Journal of Medicine, 1991
• Changes in hypertension treatment and in congestive heart failure mortality in the United States.
  Hypertension, 1989
• Effects of Enalapril on Mortality in Severe Congestive Heart Failure
  New England Journal of Medicine, 1987